×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Heal... [13]
Institute of Chi... [7]
THE STATE KEY LA... [3]
Authors
HU YUANJIA [4]
ZHAO QI [3]
WANG YITAO [2]
XU REN HE [2]
LU JINJIAN [2]
HU HAO [2]
More...
Document Type
Journal article [16]
Book chapter [1]
Conference paper [1]
Other [1]
Review article [1]
Date Issued
2024 [2]
2023 [4]
2022 [2]
2021 [1]
2017 [3]
2016 [1]
More...
Language
英語English [19]
Source Publication
Acta Pharmaceuti... [2]
Frontiers in Imm... [2]
MABS [2]
Advanced Healthc... [1]
Antibodies [1]
BBA CLINICAL [1]
More...
Indexed By
SCIE [11]
ESCI [1]
SSCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 20
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies
Journal article
Jin, Haochun, Cui, Dianxin, Fan, Yu, Li, Guodong, Zhong, Zhangfeng, Wang, Yitao. Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies[J]. Drug Discovery Today, 2024, 29(3), 103885.
Authors:
Jin, Haochun
;
Cui, Dianxin
;
Fan, Yu
;
Li, Guodong
;
Zhong, Zhangfeng
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
6
IF:
6.5
/
7.3
|
Submit date:2024/04/02
Antibodies
Bioaffinity Strategy
Drug Discovery
Natural Products
Small Molecule
Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao (Frontiers in Immunology, (2023), 14, (1131985), 10.3389/fimmu.2023.1131985)
Other
2024-01-01
Authors:
Ng, Hoi Man
;
Lei, Chon Lok
;
Fu, Siyi
;
Li, Enqin
;
Leong, Sek In
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2024/05/16
Antibodies
Heterologous Vaccinations
Inactivated Vaccine
Macao
Mrna Vaccine
Nucleocapsid Proteins
Sars-cov-2
Spike Proteins
A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov
Journal article
Yang, Jing, Kang, Heming, Lyu, Liyang, Xiong, Wei, Hu, Yuanjia. A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov[J]. Discover Oncology, 2023, 14(1), 151.
Authors:
Yang, Jing
;
Kang, Heming
;
Lyu, Liyang
;
Xiong, Wei
;
Hu, Yuanjia
Favorite
|
TC[WOS]:
7
TC[Scopus]:
7
|
Submit date:2023/09/21
Bispecific Antibodies
Combination Therapy
Immuno-oncology Therapy
Kinase Inhibitors
Pd-1/pd-l1 Inhibitors
Targeted Therapy
Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao
Journal article
Ng,Hoi Man, Lei,Chon Lok, Fu,Siyi, Li,Enqin, Leong,Sek In, Nip,Chu Iong, Choi,Nga Man, Lai,Kai Seng, Tang,Xi Jun, Lei,Chon Leng, Xu,Ren He. Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao[J]. Frontiers in Immunology, 2023, 14.
Authors:
Ng,Hoi Man
;
Lei,Chon Lok
;
Fu,Siyi
;
Li,Enqin
;
Leong,Sek In
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
2
IF:
5.7
/
6.8
|
Submit date:2023/08/03
Antibodies
Heterologous Vaccinations
Inactivated Vaccine
Macao
Mrna Vaccine
Nucleocapsid Proteins
Sars-cov-2
Spike Proteins
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives
Journal article
Ye,Zi Han, Yu,Wei Bang, Huang,Mu Yang, Chen,Jun, Lu,Jin Jian. Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives[J]. Acta Pharmaceutica Sinica B, 2023, 13(4), 1467-1487.
Authors:
Ye,Zi Han
;
Yu,Wei Bang
;
Huang,Mu Yang
;
Chen,Jun
;
Lu,Jin Jian
Favorite
|
TC[WOS]:
9
TC[Scopus]:
10
IF:
14.7
/
14.1
|
Submit date:2023/08/03
Bispecific Antibodies
Cancer
Cd47
Clinical Data
Combination Strategies
Future Perspectives
Mechanisms
Preclinical Data
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives
Review article
2023
Authors:
Ye, Zi Han
;
Yu, Wei Bang
;
Huang, Mu Yang
;
Chen, Jun
;
Lu, Jin Jian
Favorite
|
TC[WOS]:
9
TC[Scopus]:
10
IF:
14.7
/
14.1
|
Submit date:2023/05/02
Bispecific Antibodies
Cancer
Cd47
Clinical Data
Combination Strategies
Future Perspectives
Mechanisms
Preclinical Data
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants
Journal article
Liao, Guochao, Lau, Hungyan, Liu, Zhongqiu, Li, Chinyu, Xu, Zeping, Qi, Xiaoxiao, Zhang, Yu, Feng, Qian, Li, Runze, Deng, Xinyu, Li, Yebo, Zhu, Qing, Zhu, Sisi, Zhou, Hua, Pan, Hudan, Fan, Xingxing, Li, Yongchao, Li, Dan, Chen, Liqing, Ke, Bixia, Cong, Zhe, Lv, Qi, Liu, Jiangning, Liang, Dan, Li, An’an, Hong, Wenshan, Bao, Linlin, Zhou, Feng, Gao, Hongbin, Liang, Shi, Huang, Bihong, Wu, Miaoli, Qin, Chuan, Ke, Changwen, Liu, Liang. Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants[J]. Virology Journal, 2022, 19(1).
Authors:
Liao, Guochao
;
Lau, Hungyan
;
Liu, Zhongqiu
;
Li, Chinyu
;
Xu, Zeping
; et al.
Favorite
|
TC[WOS]:
5
TC[Scopus]:
5
IF:
4.0
/
3.8
|
Submit date:2023/01/30
Neutralizing Antibodies
Raav5
Sars-cov-2
Vaccine
Virus Challenge
Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method
Journal article
Fu, Shengyu, Zhao, Qi. Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method[J]. Antibodies, 2022, 11(3), 53.
Authors:
Fu, Shengyu
;
Zhao, Qi
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
3.0
/
4.7
|
Submit date:2022/08/27
Cd22
Elisa
Monoclonal Antibodies
Anti-fouling poly adenine coating combined with highly specific CD20 epitope mimetic peptide for rituximab detection in clinical patients’ plasma
Journal article
Huang,Shengfeng, Tang,Rentao, Zhang,Tingting, Zhao,Jing, Jiang,Zhengjin, Wang,Qiqin. Anti-fouling poly adenine coating combined with highly specific CD20 epitope mimetic peptide for rituximab detection in clinical patients’ plasma[J]. Biosensors and Bioelectronics, 2021, 171(112678).
Authors:
Huang,Shengfeng
;
Tang,Rentao
;
Zhang,Tingting
;
Zhao,Jing
;
Jiang,Zhengjin
; et al.
Favorite
|
TC[WOS]:
24
TC[Scopus]:
25
IF:
10.7
/
9.9
|
Submit date:2021/03/02
Anti-fouling Coating
Poly Adenine
Epitope Mimetic Peptide
Rituximab
Therapeutic Monoclonal Antibodies
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects
Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:135-158
Authors:
Tianhong Yin
;
Xiangjun Kong
;
Yitao Wang
;
Xin Chen
;
Yuanjia Hu
; et al.
Favorite
|
|
Submit date:2019/01/14
Monoclonal Antibodies
Research And Development
Network Analysis
Institutional Collaboration Network
Country-based Collaboration Network